R
Robert W. Ross
Researcher at Genentech
Publications - 3
Citations - 11144
Robert W. Ross is an academic researcher from Genentech. The author has contributed to research in topics: Genetic enhancement & Hazard ratio. The author has an hindex of 3, co-authored 3 publications receiving 10485 citations.
Papers
More filters
Journal ArticleDOI
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
Herbert Hurwitz,Louis Fehrenbacher,William Novotny,Thomas Cartwright,John D. Hainsworth,W. Heim,Jordan Berlin,Ari David Baron,Susan Griffing,Eric Holmgren,Napoleone Ferrara,Gwen Fyfe,Beth Rogers,Robert W. Ross,Fairooz F. Kabbinavar +14 more
TL;DR: The addition of bevacizumab to fluorouracil-based combination chemotherapy results in statistically significant and clinically meaningful improvement in survival among patients with metastatic colorectal cancer.
Journal ArticleDOI
Gene Therapy in a Patient with Sickle Cell Disease.
Jean-Antoine Ribeil,Salima Hacein-Bey-Abina,Emmanuel Payen,Alessandra Magnani,Michaela Semeraro,Elisa Magrin,Laure Caccavelli,Bénédicte Neven,Philippe Bourget,Wassim El Nemer,Pablo Bartolucci,Leslie Weber,Hervé Puy,Jean-François Meritet,David Grevent,Yves Beuzard,Stany Chrétien,Thibaud Lefebvre,Robert W. Ross,Olivier Negre,Gabor Istvan Veres,Laura Sandler,Sandeep Soni,Mariane de Montalembert,Stéphane Blanche,Philippe Leboulch,Marina Cavazzana +26 more
TL;DR: First patient treated with lentiviral vector–mediated addition of an antisickling β‐globin gene into autologous hematopoietic stem cells without recurrence of sickle crises and with correction of the biologic hallmarks of the disease is described.
Journal ArticleDOI
Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia
Alexis A. Thompson,Mark C. Walters,Janet L. Kwiatkowski,John E.J. Rasko,John E.J. Rasko,John E.J. Rasko,Jean-Antoine Ribeil,Suradej Hongeng,Elisa Magrin,Gary J. Schiller,Emmanuel Payen,Michaela Semeraro,Despina Moshous,François Lefrère,Hervé Puy,Philippe Bourget,Alessandra Magnani,Laure Caccavelli,Jean-Sebastien Diana,Felipe Suarez,Fabrice Monpoux,Valentine Brousse,Catherine Poirot,Catherine Poirot,Chantal Brouzes,Jean-François Meritet,Corinne Pondarré,Yves Beuzard,Stany Chrétien,Thibaud Lefebvre,David T. Teachey,Usanarat Anurathapan,P. Joy Ho,P. Joy Ho,Christof von Kalle,Morris Kletzel,Elliott Vichinsky,Sandeep Soni,Gabor Istvan Veres,Olivier Negre,Robert W. Ross,David Davidson,Alexandria Petrusich,Laura Sandler,Mohammed Asmal,Olivier Hermine,Mariane de Montalembert,Salima Hacein-Bey-Abina,Stéphane Blanche,Philippe Leboulch,Philippe Leboulch,Philippe Leboulch,Marina Cavazzana +52 more
TL;DR: Gene therapy with autologous CD34+ cells transduced with the BB305 vector reduced or eliminated the need for long‐term red‐cell transfusions in 22 patients with severe β‐thalassemia without serious adverse events related to the drug product.